First-line treatment of patients with metastatic pancreatic cancer: results of a Phase II trial with S-1 (CESAR-Study group)

Int J Clin Pharmacol Ther. 2010 Jul;48(7):470-2. doi: 10.5414/cpp48470.
No abstract available

Publication types

  • Clinical Trial, Phase II

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Drug Combinations
  • Humans
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Oxonic Acid / adverse effects
  • Oxonic Acid / therapeutic use*
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / pathology
  • Tegafur / adverse effects
  • Tegafur / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid